IMMUTEP LIMITED - AMER
2.0500
07-October-24 15:59:57
15 minutes delayed
Stocks
0.0000
0.00%
Today's range
2.0200 - 2.0900
ISIN
N/A
Source
NASDAQ
-
Immutep Quarterly Activities Report Q4 FY23
31 Jul 2023 08:00:01 By Nasdaq GlobeNewswire
-
31 Jul 2023 08:00:01 By Nasdaq GlobeNewswire
-
28 Jul 2023 08:00:00 By Nasdaq GlobeNewswire
-
Immutep Completes A$80 Million Capital Raise
27 Jun 2023 08:00:01 By Nasdaq GlobeNewswire
-
27 Jun 2023 08:00:01 By Nasdaq GlobeNewswire
-
Immutep Granted United States Patent for IMP761, a First-in-Class Agonist Antibody Targeting LAG-3
20 Jun 2023 08:00:01 By Nasdaq GlobeNewswire
-
Immutep to Participate at the Jefferies Healthcare Conference
07 Jun 2023 08:00:00 By Nasdaq GlobeNewswire
-
05 Jun 2023 08:00:01 By Nasdaq GlobeNewswire
-
02 Jun 2023 08:00:00 By Nasdaq GlobeNewswire
-
Immutep Selects Charles River Laboratories for IMP761’s GLP Toxicology Study
29 May 2023 08:00:00 By Nasdaq GlobeNewswire
-
Immutep Announces Publication of Abstracts for ASCO 2023 Annual Meeting
26 May 2023 08:00:00 By Nasdaq GlobeNewswire
-
Immutep Doses First Patient in AIPAC-003 Phase II/III Trial for Metastatic Breast Cancer
25 May 2023 08:00:00 By Nasdaq GlobeNewswire
-
Immutep Announces Promising New Clinical Data from Triple Combination Therapy in INSIGHT-003 Trial
24 May 2023 08:00:01 By Nasdaq GlobeNewswire
-
17 May 2023 08:00:00 By Nasdaq GlobeNewswire
-
16 May 2023 08:00:01 By Nasdaq GlobeNewswire
-
Immutep to Participate in the JMP Securities Life Sciences Conference
09 May 2023 08:00:01 By Nasdaq GlobeNewswire
-
02 May 2023 08:00:01 By Nasdaq GlobeNewswire
-
01 May 2023 08:00:01 By Nasdaq GlobeNewswire
-
Immutep Quarterly Activities Report
27 Apr 2023 08:00:02 By Nasdaq GlobeNewswire
-
Immutep Announces Presentation of New TACTI-002 Data at the 2023 ASCO Annual Meeting
26 Apr 2023 10:00:00 By Nasdaq GlobeNewswire